Ahmed Ludvigsen Al-Mashhadi, MD, of the Aalborg University Hospital, Aalborg, Denmark, discusses a study presented by the NORDIC lymphoma group in limited stage peripheral T-cell lymphoma patients after CHOP-like therapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
